253 related articles for article (PubMed ID: 17151338)
1. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
[TBL] [Abstract][Full Text] [Related]
2. FSHD region gene 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy.
Wuebbles RD; Hanel ML; Jones PL
Dis Model Mech; 2009; 2(5-6):267-74. PubMed ID: 19383939
[TBL] [Abstract][Full Text] [Related]
3. Testing the effects of FSHD candidate gene expression in vertebrate muscle development.
Wuebbles RD; Long SW; Hanel ML; Jones PL
Int J Clin Exp Pathol; 2010 Mar; 3(4):386-400. PubMed ID: 20490329
[TBL] [Abstract][Full Text] [Related]
4. Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy.
Ricci G; Scionti I; Sera F; Govi M; D'Amico R; Frambolli I; Mele F; Filosto M; Vercelli L; Ruggiero L; Berardinelli A; Angelini C; Antonini G; Bucci E; Cao M; Daolio J; Di Muzio A; Di Leo R; Galluzzi G; Iannaccone E; Maggi L; Maruotti V; Moggio M; Mongini T; Morandi L; Nikolic A; Pastorello E; Ricci E; Rodolico C; Santoro L; Servida M; Siciliano G; Tomelleri G; Tupler R
Brain; 2013 Nov; 136(Pt 11):3408-17. PubMed ID: 24030947
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of facioscapulohumeral muscular dystrophy.
Tupler R; Gabellini D
Cell Mol Life Sci; 2004 Mar; 61(5):557-566. PubMed ID: 15004695
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation differs in affected facioscapulohumeral muscular dystrophy patients compared to asymptomatic related carriers.
Arashiro P; Eisenberg I; Kho AT; Cerqueira AM; Canovas M; Silva HC; Pavanello RC; Verjovski-Almeida S; Kunkel LM; Zatz M
Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6220-5. PubMed ID: 19339494
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive expression analysis of FSHD candidate genes at the mRNA and protein level.
Klooster R; Straasheijm K; Shah B; Sowden J; Frants R; Thornton C; Tawil R; van der Maarel S
Eur J Hum Genet; 2009 Dec; 17(12):1615-24. PubMed ID: 19809486
[TBL] [Abstract][Full Text] [Related]
8. Rbfox1 downregulation and altered calpain 3 splicing by FRG1 in a mouse model of Facioscapulohumeral muscular dystrophy (FSHD).
Pistoni M; Shiue L; Cline MS; Bortolanza S; Neguembor MV; Xynos A; Ares M; Gabellini D
PLoS Genet; 2013; 9(1):e1003186. PubMed ID: 23300487
[TBL] [Abstract][Full Text] [Related]
9. Facioscapulohumeral muscular dystrophy.
Statland J; Tawil R
Neurol Clin; 2014 Aug; 32(3):721-8, ix. PubMed ID: 25037087
[TBL] [Abstract][Full Text] [Related]
10. Clinical Application of Optical Genome Mapping for Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy.
Shim Y; Seo J; Lee ST; Choi JR; Choi YC; Shin S; Park HJ
Ann Lab Med; 2024 Sep; 44(5):437-445. PubMed ID: 38724225
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers.
Rahimov F; King OD; Leung DG; Bibat GM; Emerson CP; Kunkel LM; Wagner KR
Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16234-9. PubMed ID: 22988124
[TBL] [Abstract][Full Text] [Related]
12. Coats syndrome in facioscapulohumeral dystrophy type 1: frequency and D4Z4 contraction size.
Statland JM; Sacconi S; Farmakidis C; Donlin-Smith CM; Chung M; Tawil R
Neurology; 2013 Mar; 80(13):1247-50. PubMed ID: 23446679
[TBL] [Abstract][Full Text] [Related]
13. Expression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patterns.
Cheli S; François S; Bodega B; Ferrari F; Tenedini E; Roncaglia E; Ferrari S; Ginelli E; Meneveri R
PLoS One; 2011; 6(6):e20966. PubMed ID: 21695143
[TBL] [Abstract][Full Text] [Related]
14. SORBS2 transcription is activated by telomere position effect-over long distance upon telomere shortening in muscle cells from patients with facioscapulohumeral dystrophy.
Robin JD; Ludlow AT; Batten K; Gaillard MC; Stadler G; Magdinier F; Wright WE; Shay JW
Genome Res; 2015 Dec; 25(12):1781-90. PubMed ID: 26359233
[TBL] [Abstract][Full Text] [Related]
15. miR-411 is up-regulated in FSHD myoblasts and suppresses myogenic factors.
Harafuji N; Schneiderat P; Walter MC; Chen YW
Orphanet J Rare Dis; 2013 Apr; 8():55. PubMed ID: 23561550
[TBL] [Abstract][Full Text] [Related]
16. Chromatin loop domain organization within the 4q35 locus in facioscapulohumeral dystrophy patients versus normal human myoblasts.
Petrov A; Pirozhkova I; Carnac G; Laoudj D; Lipinski M; Vassetzky YS
Proc Natl Acad Sci U S A; 2006 May; 103(18):6982-7. PubMed ID: 16632607
[TBL] [Abstract][Full Text] [Related]
17. Dynamic transcriptomic analysis reveals suppression of PGC1α/ERRα drives perturbed myogenesis in facioscapulohumeral muscular dystrophy.
Banerji CRS; Panamarova M; Pruller J; Figeac N; Hebaishi H; Fidanis E; Saxena A; Contet J; Sacconi S; Severini S; Zammit PS
Hum Mol Genet; 2019 Apr; 28(8):1244-1259. PubMed ID: 30462217
[TBL] [Abstract][Full Text] [Related]
18. A nuclear matrix attachment site in the 4q35 locus has an enhancer-blocking activity in vivo: implications for the facio-scapulo-humeral dystrophy.
Petrov A; Allinne J; Pirozhkova I; Laoudj D; Lipinski M; Vassetzky YS
Genome Res; 2008 Jan; 18(1):39-45. PubMed ID: 18032730
[TBL] [Abstract][Full Text] [Related]
19. The cell biology of disease: FSHD: copy number variations on the theme of muscular dystrophy.
Cabianca DS; Gabellini D
J Cell Biol; 2010 Dec; 191(6):1049-60. PubMed ID: 21149563
[TBL] [Abstract][Full Text] [Related]
20. DNA replication timing is maintained genome-wide in primary human myoblasts independent of D4Z4 contraction in FSH muscular dystrophy.
Pope BD; Tsumagari K; Battaglia D; Ryba T; Hiratani I; Ehrlich M; Gilbert DM
PLoS One; 2011; 6(11):e27413. PubMed ID: 22096571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
